Literature DB >> 33307427

The entropic tongue: Disorganization of natural language under LSD.

Camila Sanz1, Carla Pallavicini2, Facundo Carrillo3, Federico Zamberlan1, Mariano Sigman4, Natalia Mota5, Mauro Copelli6, Sidarta Ribeiro5, David Nutt7, Robin Carhart-Harris7, Enzo Tagliazucchi8.   

Abstract

Serotonergic psychedelics have been suggested to mirror certain aspects of psychosis, and, more generally, elicit a state of consciousness underpinned by increased entropy of on-going neural activity. We investigated the hypothesis that language produced under the effects of lysergic acid diethylamide (LSD) should exhibit increased entropy and reduced semantic coherence. Computational analysis of interviews conducted at two different time points after 75 μg of intravenous LSD verified this prediction. Non-semantic analysis of speech organization revealed increased verbosity and a reduced lexicon, changes that are more similar to those observed during manic psychoses than in schizophrenia, which was confirmed by direct comparison with reference samples. Importantly, features related to language organization allowed machine learning classifiers to identify speech under LSD with accuracy comparable to that obtained by examining semantic content. These results constitute a quantitative and objective characterization of disorganized natural speech as a landmark feature of the psychedelic state.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Entropy; LSD; Natural language; Psychedelics; Psychosis

Year:  2020        PMID: 33307427     DOI: 10.1016/j.concog.2020.103070

Source DB:  PubMed          Journal:  Conscious Cogn        ISSN: 1053-8100


  9 in total

1.  Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow.

Authors:  Isabel Wießner; Marcelo Falchi; Fernanda Palhano-Fontes; Lucas Oliveira Maia; Amanda Feilding; Sidarta Ribeiro; Natália Bezerra Mota; Draulio B Araujo; Luís Fernando Tófoli
Journal:  Psychopharmacology (Berl)       Date:  2021-10-28       Impact factor: 4.530

2.  Natural language signatures of psilocybin microdosing.

Authors:  Camila Sanz; Federico Cavanna; Stephanie Muller; Laura de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar; Facundo Carrillo; Adolfo M García; Carla Pallavicini; Enzo Tagliazucchi
Journal:  Psychopharmacology (Berl)       Date:  2022-06-09       Impact factor: 4.415

Review 3.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

4.  Analysis of recreational psychedelic substance use experiences classified by substance.

Authors:  Adrian Hase; Max Erdmann; Verena Limbach; Gregor Hasler
Journal:  Psychopharmacology (Berl)       Date:  2022-01-15       Impact factor: 4.530

Review 5.  Prefrontal contributions to the stability and variability of thought and conscious experience.

Authors:  Andre Zamani; Robin Carhart-Harris; Kalina Christoff
Journal:  Neuropsychopharmacology       Date:  2021-09-20       Impact factor: 7.853

6.  Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.

Authors:  Drummond E-Wen McCulloch; Maria Zofia Grzywacz; Martin Korsbak Madsen; Peter Steen Jensen; Brice Ozenne; Sophia Armand; Gitte Moos Knudsen; Patrick MacDonald Fisher; Dea Siggaard Stenbæk
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 7.  Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs.

Authors:  Enzo Tagliazucchi
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

Review 8.  Psychedelic Cognition-The Unreached Frontier of Psychedelic Science.

Authors:  Maria Bălăeţ
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

9.  Automated text-level semantic markers of Alzheimer's disease.

Authors:  Camila Sanz; Facundo Carrillo; Andrea Slachevsky; Gonzalo Forno; Maria Luisa Gorno Tempini; Roque Villagra; Agustín Ibáñez; Enzo Tagliazucchi; Adolfo M García
Journal:  Alzheimers Dement (Amst)       Date:  2022-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.